Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

the press release.

GAAP net loss for the nine months ended September 30, 2009 was $5.2 million ($0.05 per diluted share), compared to GAAP net income of $6.3 million ($0.06 per diluted share) for the nine months ended September 30, 2008. Non-GAAP net income was $33.9 million ($0.33 per diluted share) for the nine months ended September 30, 2009, compared to non-GAAP net income of $21.9 million ($0.21 per diluted share) for the nine months ended September 30, 2008.

As of September 30, 2009, BioMarin had cash, cash equivalents and short and long-term investments totaling $491.8 million.

"During the quarter, we continued to advance our clinical pipeline as we completed enrollment for the Phase I/II study of GALNS for MPS IVA and initiated the Phase II trial of PEG-PAL for PKU. On the commercial front, we were issued patents covering stable tablet formulation and the once daily dosing regimen for Kuvan, and received claims covering the approved administration of Kuvan with food. We believe that these patents are significant in extending protection beyond orphan drug market exclusivity," said Jean-Jacques Bienaime, Chief Executive Officer of BioMarin. "Based on our performance to date, we have narrowed the guidance range on a few items to reflect increased visibility into the year, including improved expectations for the bottom line. Our commercial products are performing well, and we continue to carefully manage expenses. We are also carefully evaluating both internal pipeline programs and external product opportunities to maximize long-term value for both the company and our shareholders. Also, as announced earlier this week, we acquired Huxley Pharmaceuticals, which is developing a proprietary form of 3,4-DAP for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome. A positive opinion was issued by the EMEA last week, and we expect to launch this product in the EU in the first quarter of 2010. This low-risk deal le
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. BioMarin to Present at the Oppenheimer Healthcare Conference
2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. BioMarin Announces FDA Approval for Kuvan
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Rigel Announces Presentations at Two Investor Conferences
10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Scientists at,deCODE genetics, Inc. (Nasdaq: DCGN ) publish ... of a common single-letter variant in the sequence ... on susceptibility to type 2,diabetes (T2D). The impact ... but unusual:,if an individual inherits it from their ... than 30% compared to those who inherit the ...
(Date:12/16/2009)... 16 Boston Scientific Corporation (NYSE: ... Directors has elected Nelda Connors as a Director. ... Electrical and Metal Products division of Tyco International. ... holding several positions in operations and general management. ... number of executive and management capacities with Ford, Chrysler ...
(Date:12/16/2009)... -- Siemens Healthcare today announced a ... to help healthcare providers pursue ... within the HITECH provision of the American ... Featuring zero-percent interest terms for qualified customers, ... payments associated with their technology investment while ...
Breaking Medicine Technology:deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4US gets a D for preterm birth rate 61481 1US gets a D for preterm birth rate 61481 2Vibrations key to efficiency of green fluorescent protein 14861 1Vibrations key to efficiency of green fluorescent protein 14861 2Vibrations key to efficiency of green fluorescent protein 14861 3Vibrations key to efficiency of green fluorescent protein 14861 4Bacterial ropes tie down shifting Southwest 10753 1Bacterial ropes tie down shifting Southwest 10753 2
... Trials Initiated, CRANBURY, N.J., March 21, 2007 ... small,molecule, orally-administered pharmacological chaperones for the,treatment of ... today,that it will present positive results from ... Plicera(TM) (isofagomine tartrate,AT2101) for Gaucher disease at ...
... Appears in Peer-Review Journal,Respiratory Medicine, SAN JOSE, ... Coalition,for Pulmonary Fibrosis (CPF) today announced a ... one of the,largest databases of information on ... the United States, was,published in Respiratory Medicine. ...
Other Medicine Technology:Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease 2Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease 3Medical Journal Publishes First Large-Scale Survey Revealing,Experiences of IPF Patients 2Medical Journal Publishes First Large-Scale Survey Revealing,Experiences of IPF Patients 3
(Date:12/16/2009)... and environmental concerns about the emerging nanotechnology industry, scientists ... of nanoparticles in municipal sewage treatment plants their ... in ACS, journal Environmental Science & Technology . ... and Hydrology and colleagues note that experts predict large ... than 1/1000th the width of a human hair ...
(Date:12/16/2009)... Immune-boosting, Newborn-Safe Skin Care Products from Episencial Offers Planet-Friendly Organics, ... Available , ... Los Angeles, CA ... values now have an authentic, affordable choice in all natural ... launches its eponymous product line for young children featuring the ...
(Date:12/16/2009)... link has been found, , , WEDNESDAY, Dec. 16 (HealthDay ... linked to food poisoning and the stomach pain and ... of some urinary tract infections. , Researchers have found ... stores and restaurants and in women with the infections. ... transmitted directly to the women through the food they ...
(Date:12/16/2009)... through annual marketing campaign , ... ... 2010 Genetown™ Hotbed Campaign as its largest yearly ... sponsored by MassBio and showcases 37 Massachusetts companies ... each entity’s brand on an electronic and printed map ...
(Date:12/16/2009)... also at all-time low, government report shows, , , WEDNESDAY, ... the United States has reached almost 78 years, a ... birth in 2007, women can expect to live to ... according to the report from the U.S. Centers for ... Americans can expect to live longer than their parents, ...
Breaking Medicine News(10 mins):Health News:Behavior modification could ease concerns about nanoparticles 2Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3Health News:Thriving Bioscience Region Leaves Its Mark 2Health News: Life Expectancy in U.S. Hits New High 2Health News: Life Expectancy in U.S. Hits New High 3
... Astrocytes called missing link between neurons, blood vessels, researchers ... brain cells called astrocytes play a key role in ... and blues on brain scans, according to a report ... , Astrocytes, previously thought of as minor players ...
... is the title of a new book that will nudge readers ... they have to improve their lives and the lives of others. ... M.D., Ph.D. guides readers through reflection on and discussion of the ... Gunderman expands on the adage, "We make a living by what ...
... -,regardless of whether they are enrolled in ... the Medicare Advantage program to fund the,Medicare ... Medicare Advantage will,have a negative effect on ... Point Presentation: http://www.ahip.org/content/default.aspx?docid=23669 , Memo ...
... Despite Outstanding Track Record of Program, Head Start Officials,Bracing ... Forward to,Working With New President, Congress to Address Long-Term ... with an effective,$1 billion cut in funding since 2002, ... no choice but to seek up to 14,000 child,enrollment ...
... raises the odds of this cluster of heart risk factors, ... risk of developing metabolic syndrome -- a group of factors ... have five common gene variations, researchers say. , But one ... add. , People with metabolic syndrome run four times ...
... Federal Reserve chairman Ben Bernanke,s,comments this week that improving ... of the biggest challenges facing the nation, plus a ... nearly 10 percent this,year, lend strong support to the ... according to U.S. Preventive Medicine, the leader,in disease prevention., ...
Other Medicine News:Health News:Star-Shaped Brain Cells Make Scans Possible 2Health News:Seniors Oppose Cutting Medicare Advantage to Fund Physician Payment Fix 2Health News:Head Start Leaders Have High Hopes for New President and Congress, But Budget 'Double Whammy' Expected to Force Cuts of Up to 14,000 Child Slots Nationwide 2Health News:Head Start Leaders Have High Hopes for New President and Congress, But Budget 'Double Whammy' Expected to Force Cuts of Up to 14,000 Child Slots Nationwide 3Health News:Head Start Leaders Have High Hopes for New President and Congress, But Budget 'Double Whammy' Expected to Force Cuts of Up to 14,000 Child Slots Nationwide 4Health News:Head Start Leaders Have High Hopes for New President and Congress, But Budget 'Double Whammy' Expected to Force Cuts of Up to 14,000 Child Slots Nationwide 5Health News:Metabolic Syndrome May Be in the Genes 2Health News:U.S. Preventive Medicine Views Bernanke's Comments as Strong Support for Prevention and Wellness Programs 2
A standard, durable and reliable indirect....
Designed to retain the desired curve during oral intubation....
Facilitates intubation of tracheal tubes....
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Medicine Products: